Skip to content ↓

Town-Gown Crown is Goal for MIT and Cambridge Chess Exhibition

Cambridge, MA--Saturday, May 20, the Cambridge community and MIT will engage in a battle of wits in a chess tournament to benefit the Cambridge School Volunteers, which provides programs of support for Cambridge school children. The exhibition match, dubbed the "Town-Gown Crown" will be a part of a day-long open tournament, sanctioned by the US Chess Federation. All proceeds from the tournament go to the Cambridge School Volunteers program.

The exhibition match will be played at 2:30 pm with two teams of four rotating people. Cambridge City Councilors Jonathan Meyers and Frank Duehay; Robin Harris, Cambridge school committee member; and a representative of Rindge and Latin High School will play for Cambridge. The MIT team will consist of three members of the MIT Chess Team and Paul Parravano, MIT assistant for community relations and one of the event's organizers.

The tournament will be held in Twenty Chimneys in the Stratton Student Center at 84 Massachusetts Avenue, from 10 am-12:15 pm and 2:30-4:45 pm. Registration will be from 8:45 am -9:45 am. Entry fee is from $10 to $20 depending on entrant's status. Boston area chess players from novice to expert are invited to join the tournament. To register or for more information, call Paul Parravano at 253-3873. Entrants may register on-site.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story